Investment trends in biosolutions
The UK biosolutions investment landscape: 2026 analysis
The global economy is at a critical juncture. From the climate crisis to supply chain volatility, the need for domestic, sustainable, and resilient industrial solutions has never been greater. At the BIA, we believe that biosolutions, the application of engineering biology to solve industrial challenges, is the key to strengthening the UK’s strategic autonomy and securing a sustainable future.
Our latest analysis provides the definitive data on the UK biosolutions industry, revealing a sector that has moved beyond emerging tech to become a billion-pund frontier indutry capable of insulating the UK from global resource shocks.
Unlocking investment: key data and trends
Scaling for global impact: an industry ready for the next stage
The UK biosolutions ecosystem is primed for its next phase of growth. The data reveals a clear shift toward maturation: in 2025, over 53% of funding was later-stage VC, signaling a sector moving rapidly from concept to commercialisation.
Capital is increasingly concentrated in ventures ready for significant scale. Agriculture and food lead this charge, attracting 52% of 2025 investment, while chemicals, materials and environmental applications continue to grow as vital domestic supply chain assets. Public funding, particularly through Innovate UK, remains a critical de-risking tool, catalysing the private capital necessary to build a resilient UK bioeconomy.
As global supply chains face increasing pressure, biotechnology is becoming central to strengthening our strategic autonomy. By driving demand for bio-based products, we can protect both our economy and the planet.
Jane Wall
Managing Director, BIA
The future is bio-engineered
The UK biosolutions sector is no longer just a laboratory success story; it is a critical security asset for the UK. As these innovative companies scale, they are building a more sustainable, self-sufficient and healthier future. We encourage policymakers, investors, and industry leaders to engage with the full report and join us in unleashing the UK’s biorevolution.